Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/18F-FDG PET

International Journal of Cardiovascular Imaging

Volumn 27, Issue 6, 2011, Pages 913-921

  Nkoulou, Rene ^a   Pazhenkottil, Aju P ^a   Buechel, Ronny R ^a   Husmann, Lars ^a   Valenta, Ines ^a   Herzog, Bernhard A ^a   Wolfrum, Mathias ^a   Ghadri, Jelena R ^a   Kaufmann, Philipp A ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

CT attenuation correction; SPECT; Viability

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TETROFOSMIN TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; CARDIOVASCULAR PARAMETERS; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER TOMOGRAPHY ATTENUATION CORRECTION; CONFERENCE PAPER; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; MYOCARDIAL PERFUSION IMAGING; MYOCARDIAL VIABILITY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIATION ATTENUATION; RIGHT CORONARY ARTERY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY CIRCULATION; CORONARY STENOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; SWITZERLAND; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 83955164351     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-010-9719-8     Document Type: Conference Paper

References (29)

1. Kaufmann PA, Camici PG (2005) Myocardial blood flow measurement by pet: Technical aspects and clinical applications. J Nucl Med 46(1):75-88 (Pubitemid 43086001)
2. Kaufmann PA (2007) 82-rubidium-the dawn of cardiac pet in europe? Eur J Nucl Med Mol Imaging 34(12): 1963-1964 (Pubitemid 50004857)
3. Fricke E, Fricke H, Weise R, Kammeier A, Hagedorn R, Lotz N, Lindner O, Tschoepe D, Burchert W (2005) Attenuation correction of myocardial spect perfusion images with low-dose ct: Evaluation of the method by comparison with perfusion pet. J Nucl Med 46(5):736-744
4. Masood Y, Liu YH, Depuey G, Taillefer R, Araujo LI, Allen S, Delbeke D, Anstett F, Peretz A, Zito MJ, Tsatkin V, Wackers FJ (2005) Clinical validation of spect attenuation correction using X-ray computed tomographyderived attenuation maps: Multicenter clinical trial with angiographic correlation. J Nucl Cardiol 12(6):676-686 (Pubitemid 43033608)
5. Schepis T, Gaemperli O, Koepfli P, Ruegg C, Burger C, Leschka S, Desbiolles L, Husmann L, Alkadhi H, Kaufmann PA (2007) Use of coronary calcium score scans from stand-alone multislice computed tomography for attenuation correction of myocardial perfusion spect. Eur J Nucl Med Mol Imaging 34(1):11-19 (Pubitemid 44885549)
6. Gaemperli O, Schepis T, Valenta I, Koepfli P, Husmann L, Scheffel H, Leschka S, Eberli FR, Luscher TF, Alkadhi H, Kaufmann PA (2008) Functionally relevant coronary artery disease: Comparison of 64-section ct angiography with myocardial perfusion spect. Radiology 248(2):414-423
7. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H (1986) Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314(14):884-888 (Pubitemid 16126116)
8. Koepfli P, Hany TF, Wyss CA, Namdar M, Burger C, Konstantinidis AV, Berthold T, Von Schulthess GK, Kaufmann PA (2004) Ct attenuation correction for myocardial perfusion quantification using a pet/ct hybrid scanner. J Nucl Med 45(4):537-542 (Pubitemid 47618582)
9. Schepis T, Gaemperli O, Treyer V, Valenta I, Burger C, Koepfli P, Namdar M, Adachi I, Alkadhi H, Kaufmann PA (2007) Absolute quantification of myocardial blood flow with 13n-ammonia and 3-dimensional pet. J Nucl Med 48(11):1783-1789 (Pubitemid 350099322)
10. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American heart association. Int J Cardiovasc Imaging 18(1):539-542 (Pubitemid 34262671)
11. Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, McKiddie F, O'Connor M, Prvulovich E, Underwood R, van Eck-Smit B (2005) Eanm/esc procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 32(7):855-897 (Pubitemid 41125431)
12. vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Schulz G, Schwarz ER, Koch KC, Uebis R, Messmer BJ, Buell U, Hanrath P (1997) Effect of myocardial viability assessed by technetium-99m-sestamibi spect and fluorine-18-fdg pet on clinical outcome in coronary artery disease. J Nucl Med 38(5):742-748
13. Schinkel AF, Poldermans D, Elhendy A, Bax JJ (2007) Assessment of myocardial viability in patients with heart failure. J Nucl Med 48(7):1135-1146 (Pubitemid 47052654)
14. Rentrop KP, Cohen M, Blanke H, Phillips RA (1985) Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5(3): 587-592 (Pubitemid 15141963)
15. Underwood SR, Bax JJ, vom Dahl J, Henein MY, Knuuti J, van Rossum AC, Schwarz ER, Vanoverschelde JL, van der Wall EE, Wijns W (2004) Imaging techniques for the assessment of myocardial hibernation. Report of a study group of the european society of cardiology. Eur Heart J 25(10):815-836 (Pubitemid 38684148)
16. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY, Garrard L, deKemp R, Guo A, Ruddy TD, Benard F, Lamy A, Iwanochko RM (2007) F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: A randomized, controlled trial (parr-2). J Am Coll Cardiol 50(20):2002-2012 (Pubitemid 350054917)
17. Iskandrian AS, Hakki AH, Kane SA, Goel IP, Mundth ED, Segal BL (1983) Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting. Am J Cardiol 51(8):1312-1316 (Pubitemid 13133071)
18. Galli M, Marcassa C, Imparato A, Campini R, Orrego PS, Giannuzzi P (1994) Effects of nitroglycerin by technetium- 99m sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 74(9):843-848 (Pubitemid 24340302)
19. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE (2002) Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol 39(7):1151-1158 (Pubitemid 34267418)
20. Rizzello V, Poldermans D, Biagini E, Schinkel AF, Boersma E, Boccanelli A, Marwick T, Roelandt JR, Bax JJ (2009) Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: Relation to viability and improvement in left ventricular ejection fraction. Heart 95(15):1273-1277
21. Gerber BL, Ordoubadi FF, Wijns W, Vanoverschelde JL, Knuuti MJ, Janier M, Melon P, Blanksma PK, Bol A, Bax JJ, Melin JA, Camici PG (2001) Positron emission tomography using(18)f-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: Optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European community concerted action multicenter study on use of (18)f-fluoro-deoxyglucose positron emission tomography for the detection of myocardial viability. Eur Heart J 22(18):1691-1701 (Pubitemid 32896369)
22. Beanlands RS, Hendry PJ, Masters RG, deKemp RA, Woodend K, Ruddy TD (1998) Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 98(19(Suppl)):II51-II56 (Pubitemid 28512165)
23. Hoefflinghaus T, Husmann L, Valenta I, Moonen C, Gaemperli O, Schepis T, Namdar M, Koepfli P, Siegrist PT, Kaufmann PA (2008) Role of attenuation correction to discriminate defects caused by left bundle branch block versus coronary stenosis in single photon emission computed tomography myocardial perfusion imaging. Clin Nucl Med 33(11):748-751
24. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Osterspey A, Tamargo J, Zamorano JL (2006) Guidelines on the management of stable angina pectoris: Executive summary: The task force on the management of stable angina pectoris of the European society of cardiology. Eur Heart J 27(11):1341-1381 (Pubitemid 43998110)
25. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA (2009) Accf/scai/sts/aats/aha/asnc 2009 appropriateness criteria for coronary revascularization: A report by the american college of cardiology foundation appropriateness criteria task force, society for cardiovascular angiography and interventions, society of thoracic surgeons, american association for thoracic surgery, american heart association, and the american society of nuclear cardiology endorsed by the american society of echocardiography, the heart failure society of America, and the society of cardiovascular computed tomography. J Am Coll Cardiol 53(6):530-553
26. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA (1994) Management of heart failure: III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 272(19):1528-1534 (Pubitemid 24340796)
27. Chareonthaitawee P, Gersh BJ, Araoz PA, Gibbons RJ (2005) Revascularization in severe left ventricular dysfunction: The role of viability testing. J Am Coll Cardiol 46(4):567-574 (Pubitemid 41132679)
28. Slart RH, Bax JJ, Sluiter WJ, van Veldhuisen DJ, Jager PL (2004) Added value of attenuation-corrected tc-99m tetrofosmin spect for the detection of myocardial viability: Comparison with fdg spect. J Nucl Cardiol 11(6):689-696 (Pubitemid 40012041)
29. Matsunari I, Boning G, Ziegler SI, Nekolla SG, Stollfuss JC, Kosa I, Ficaro EP, Schwaiger M (1998) Attenuationcorrected 99mtc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: Comparison with positron emission tomography using 18ffluorodeoxyglucose. J Am Coll Cardiol 32(4):927-935 (Pubitemid 28459580)